Clorox's (CLX) Neutral Rating Reaffirmed at DA Davidson

Clorox (NYSE:CLX - Get Free Report)'s stock had its "neutral" rating reiterated by stock analysts at DA Davidson in a research note issued on Wednesday, Benzinga reports. They currently have a $162.00 target price on the stock. DA Davidson's target price would suggest a potential upside of 13.85% from the stock's previous close.

A number of other equities research analysts have also commented on CLX. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $155.00 to $151.00 and set a "hold" rating on the stock in a research report on Wednesday. Jefferies Financial Group upgraded Clorox from an "underperform" rating to a "hold" rating and set a $145.00 target price on the stock in a report on Tuesday, March 26th. The Goldman Sachs Group started coverage on shares of Clorox in a report on Friday, March 1st. They set a "sell" rating and a $140.00 price target for the company. Barclays reduced their price objective on shares of Clorox from $148.00 to $136.00 and set an "underweight" rating on the stock in a research note on Wednesday, April 10th. Finally, UBS Group lifted their target price on shares of Clorox from $145.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, February 2nd. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. Based on data from MarketBeat, Clorox has a consensus rating of "Hold" and a consensus price target of $148.63.

Clorox Trading Down 0.1 %

Clorox stock traded down $0.19 during trading hours on Wednesday, hitting $142.29. The stock had a trading volume of 839,125 shares, compared to its average volume of 1,209,846. The stock has a market cap of $17.66 billion, a price-to-earnings ratio of 225.51, a P/E/G ratio of 2.19 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The business's 50 day simple moving average is $150.67 and its 200-day simple moving average is $141.68. Clorox has a one year low of $114.68 and a one year high of $178.21.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company's revenue for the quarter was up 16.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.98 EPS. On average, equities analysts predict that Clorox will post 5.52 EPS for the current fiscal year.

Hedge Funds Weigh In On Clorox

A number of large investors have recently modified their holdings of CLX. Tyler Stone Wealth Management bought a new position in shares of Clorox in the second quarter valued at $25,000. O Dell Group LLC acquired a new position in Clorox during the 4th quarter valued at about $28,000. Strategic Investment Solutions Inc. IL bought a new stake in Clorox during the 1st quarter worth approximately $31,000. Northwest Financial Advisors purchased a new stake in shares of Clorox in the fourth quarter worth approximately $29,000. Finally, GoalVest Advisory LLC bought a new position in shares of Clorox in the first quarter valued at approximately $31,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.